Ensemble Therapeutics Corporation
Records under this name other than patents Ensemble Therapeutics Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 5 of 5 · Back to Ensemble Therapeutics Corporation
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,605,022 | Macrocyclic compounds for inhibition of inhibitors of apoptosis Lapsed on the fee record Ended Mar 28, 2021 · USPTO record | Lapsed on the fee record | Ended Mar 28, 2021 | USPTO record |
| US 9,284,283 | Macrocyclic compounds for modulating IL-17 Lapsed on the fee record Ended Mar 15, 2020 · USPTO record | Lapsed on the fee record | Ended Mar 15, 2020 | USPTO record |
| US 7,968,289 | Turn over probes and use thereof for nucleic acid detection Lapsed on the fee record Ended Jun 28, 2019 · USPTO record | Lapsed on the fee record | Ended Jun 28, 2019 | USPTO record |
| US 8,338,565 | Macrocyclic compounds for inhibition of tumor necrosis factor alpha Lapsed on the fee record Ended Dec 25, 2016 · USPTO record | Lapsed on the fee record | Ended Dec 25, 2016 | USPTO record |
| US 8,071,388 | Compositions and methods for biodetection by nucleic acid-templated chemistry Lapsed on the fee record Ended Dec 6, 2015 · USPTO record | Lapsed on the fee record | Ended Dec 6, 2015 | USPTO record |